These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2854066)

  • 21. Characteristics of the phenylalkylamine binding site in canine cardiac sarcolemmal membranes.
    Dumont L; Williams JS; Vaghy PL; Schwartz A
    Basic Res Cardiol; 1988; 83(4):369-75. PubMed ID: 2847707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites.
    Mir AK; Spedding M
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):469-77. PubMed ID: 2438510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
    Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
    Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM; Santos SV; Carvalho AP
    Eur J Pharmacol; 1986 Nov; 131(1):1-12. PubMed ID: 3816939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of different photoperiod exposure on [3H]imipramine binding and serotonin uptake in the rat brain.
    Rovescalli AC; Brunello N; Riva M; Galimberti R; Racagni G
    J Neurochem; 1989 Feb; 52(2):507-14. PubMed ID: 2463336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain.
    Srinivas BN; Subhash MN; Vinod KY
    Neurochem Int; 2001 Jun; 38(7):573-9. PubMed ID: 11290382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors.
    Hrdina PD
    Eur J Pharmacol; 1988 Mar; 148(2):279-82. PubMed ID: 3259932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific tricyclic antidepressant binding sites in rat brain.
    Raisman R; Briley M; Langer SZ
    Nature; 1979 Sep; 281(5727):148-50. PubMed ID: 471061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
    Lesnichuk SA; Katukov VIu; Porodenko NV
    Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localisation of tricyclic antidepressant binding sites on serotonin nerve terminals.
    Sette M; Raisman R; Briley M; Langer SZ
    J Neurochem; 1981 Jul; 37(1):40-2. PubMed ID: 7252512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricyclic antidepressants inhibit voltage-dependent calcium channels and Na(+)-Ca2+ exchange in rat brain cortex synaptosomes.
    Lavoie PA; Beauchamp G; Elie R
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1414-8. PubMed ID: 2285885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.